Overall rank by patents
#24,834
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 12 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
National holds 11 US patents across 12 technology areas, rank #24,834 of 50,000 tracked assignees.
National Institutes OF Health (nih) has been granted 11 US utility patents between 2015 and 2023, placing National Institutes OF Health (nih) at rank #24,834 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, National Institutes OF Health (nih) is one of the more focused assignees in the PatentsView dataset. By volume, National sits between Nanograf Corporation (11 patents, rank #24,830) and NCM Innovations (pty) Ltd (11 patents, rank #24,838) - the closest US assignees by grant volume. The composite Innovation Score of 36.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 6 in the 2015–2019 window, a -17% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. National Institutes OF Health (nih)'s 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark National Institutes OF Health (nih) against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NANOGRAF CORPORATION
11 patents
NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
11 patents
NATIONAL DONG HWA UNIVERSITY
11 patents
NATIONAL GUARD PRODUCTS, INC.
11 patents
NATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL SCIENCE
11 patents
NATIVE INSTRUMENTS GMBH
11 patents
NCIP INC.
11 patents
NCM INNOVATIONS (PTY) LTD
11 patents
NATIONAL INSTITUTES OF HEALTH (NIH)
11 patents
What this shows National holds 11 patents at rank #24,834, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
National's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
37 Top 45% higher than 55% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 2 | 18.2% |
| 2018 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2021 | 2 | 18.2% |
| 2022 | 1 | 9.1% |
| 2023 | 2 | 18.2% |
Top 12 of 12 technology areas
Overall rank by patents
#24,834
Across all tracked assignees
36.8 out of 100
How to use this portfolio
National's 11 grants land it in the top 45% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.